MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 106 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CITIGROUP INC | 655 | $5,273 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 138,929 | $1,118,378 | 0.00% |
| GOLDMAN SACHS GROUP INC | 116,201 | $935,418 | 0.00% |
| MORGAN STANLEY | 47,147 | $379,534 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 155,844 | $1,254,544 | 0.00% |
| Invesco Ltd. | 43,942 | $353,733 | 0.00% |
| Lindbrook Capital, LLC | 242 | $1,948 | 0.00% |
| WOLVERINE TRADING, LLC | 48,000 | $386,400 | 0.00% |
| WOLVERINE TRADING, LLC | 21,300 | $171,465 | 0.00% |
| WOLVERINE TRADING, LLC | 13,202 | $106,276 | 0.00% |
| BARCLAYS PLC | 9,012 | $73 | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2,914 | $23,458 | 0.00% |
| Walleye Trading LLC | 6,200 | $49,910 | 0.00% |
| Walleye Trading LLC | 9,600 | $77,280 | 0.00% |
| Walleye Trading LLC | 19,683 | $158,448 | 0.00% |
| Bank of New York Mellon Corp | 163,404 | $1,315,403 | 0.00% |
| JPMORGAN CHASE & CO | 43,951 | $353,806 | 0.00% |
| Citadel Advisors | 118,300 | $952,315 | 0.00% |
| Citadel Advisors | 53,800 | $433,090 | 0.00% |
| CWM, LLC | 22 | $0 | 0.00% |
This page lists MARINUS PHARMACEUTICALS INC's shareholders in Q3 2023. To view MARINUS PHARMACEUTICALS INC's shareholder history, click here.